Data gathered: June 24
Alternative Data for Liquidia
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 84 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 14 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 18 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,905 | Sign up | Sign up | Sign up |
| Twitter Followers | 939 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 47 | Sign up | Sign up | Sign up |
| Linkedin Employees | 180 | Sign up | Sign up | Sign up |
About Liquidia
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
| Price | $13.26 |
| Target Price | Sign up |
| Volume | 2,020,000 |
| Market Cap | $1.13B |
| Year Range | $9.82 - $19.3 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Rhumbline Advisers Boosts Position in Liquidia Technologies, Inc. (NASDAQ:LQDA)June 20 - ETF Daily News |
|
SG Americas Securities LLC Buys Shares of 61,735 Liquidia Technologies, Inc. (NASDAQ:LQDA)June 19 - ETF Daily News |
 |
Liquidia (NASDAQ:LQDA) Price Target Raised to $25.00June 14 - ETF Daily News |
|
Liquidia (NASDAQ:LQDA) Stock Price Up 3.1% After Analyst UpgradeJune 12 - ETF Daily News |
|
Liquidia (NASDAQ:LQDA) Price Target Cut to $23.00 by Analysts at Bank of AmericaJune 12 - ETF Daily News |
 |
Liquidia: Competitor Insmed's Stunning PAH Data Arrives At Precisely The Wrong TimeJune 11 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 3.1M | 1.5M | 1.6M | -38M | 0 | -0.450 |
| Q4 '24 | 2.9M | 1.4M | 1.6M | -38M | -33M | -0.450 |
| Q3 '24 | 4.4M | 1.6M | 2.9M | -23M | -20M | -0.388 |
| Q2 '24 | 3.7M | 1.5M | 2.2M | -28M | -25M | -0.370 |
| Q1 '24 | 3M | 1.8M | 1.2M | -41M | -38M | -0.540 |
Insider Transactions View All
| Adair Jason filed to sell 193,735 shares at $17. June 5 '25 |
| Moomaw Scott filed to sell 224,921 shares at $17. June 5 '25 |
| Saggar Rajeev filed to sell 273,209 shares at $17. June 5 '25 |
| Schundler Russell filed to sell 582,054 shares at $17. June 5 '25 |
| JEFFS ROGER filed to sell 1,044,979 shares at $17. June 5 '25 |
Similar companies
Read more about Liquidia (LQDA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Liquidia?
The Market Cap of Liquidia is $1.13B.
What is the current stock price of Liquidia?
Currently, the price of one share of Liquidia stock is $13.26.
How can I analyze the LQDA stock price chart for investment decisions?
The LQDA stock price chart above provides a comprehensive visual representation of Liquidia's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Liquidia shares. Our platform offers an up-to-date LQDA stock price chart, along with technical data analysis and alternative data insights.
Does LQDA offer dividends to its shareholders?
As of our latest update, Liquidia (LQDA) does not offer dividends to its shareholders. Investors interested in Liquidia should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Liquidia?
Some of the similar stocks of Liquidia are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.